Natixis

SEC CIK: 0001274981
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overview All 13F holders of AVXL Full Q2 2026 holdings

Shares (Q2 2026): 360
Value: $932
% of portfolio: <0.1%
Quarters held: 2; Since Q2 2023

Holdings of AVXL by Natixis, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	360	$932	<0.1%	+360	New	Holders
Q3 2023	0	$0	0.0%	−8,000−100.0%	Sold out	Holders
Q2 2023	8,000	$65.0K	<0.1%	+8,000	New	Holders